Shota Nobumori
Papers
1
Total Citations
1
H-Index
1
About
Dr. Shota Nobumori is a pioneering urologic surgeon whose work sits at the intersection of advanced robotics and cutting-edge immunotherapy for renal cell carcinoma (RCC). His primary research focus is the refinement of robot-assisted radical nephrectomy with inferior vena cava thrombectomy (RARN-IVCT), a technically demanding procedure for managing advanced kidney cancers with vascular invasion. Dr. Nobumori’s major contribution lies in demonstrating the feasibility and safety of this complex surgery in patients who have received neoadjuvant immunotherapy, specifically the combination of pembrolizumab and axitinib. His 2024 case report, which has garnered early citations, is among the first to document a successful RARN-IVCT following this targeted drug regimen, suggesting that preoperative immunotherapy does not preclude—and may even facilitate—a minimally invasive surgical approach. This work bridges a critical gap between medical and surgical oncology, offering a potential pathway for patients with initially unresectable disease. By integrating state-of-the-art robotic techniques with modern systemic therapies, Dr. Nobumori is helping to redefine the treatment landscape for advanced RCC, providing hope for improved outcomes in a challenging patient population.
Research Focus
Key Achievements
Top Papers
- 1